Z-1575-2023 Class II Ongoing

Recalled by Diagnostica Stago, Inc. — Parsippany, NJ

FDA device recall Z-1575-2023 was initiated by Diagnostica Stago, Inc. on Mar 22, 2023 and is designated Class II. Reason for recall: An internal investigation identified a bug in this firmware version, resulting in the following:Intermittent shortened coagulation times and an increased frequency of occurrence of a technical error… The recall status is ongoing. Affected quantity: 6 analyzers.

Recall details

Product Type
Devices
Report Date
May 17, 2023
Initiation Date
Mar 22, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6 analyzers

Product description

STA R Max fully automatic clinical instrument designed to perform tests on human plasmas, Reference Numbers 59013 and 59026

Reason for recall

An internal investigation identified a bug in this firmware version, resulting in the following:Intermittent shortened coagulation times and an increased frequency of occurrence of a technical error reported by the analyzer (error 13).

Distribution pattern

US Nationwide distribution in the states of IL, MA, MN, NE, TX, and WI.

Code information

UDI-DI: 036074505901; Serial Numbers: CP86010393 DB68093186 CP87010814 CP86070669 CP86090743 CP86090744

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1575-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1575-2023. Report a data issue: hello@regdatalab.com.